Vieweg V, Pandurangi A, Levenson J, Silverman J
Department of Psychiatry, Medical College of Virginia, Richmond 23298-0710, USA.
Int J Psychiatry Med. 1994;24(4):275-303. doi: 10.2190/5WG5-VV1V-BXAD-805K.
The authors seek to extend understanding and treatment of hospitalized schizophrenics presenting with complications of polydipsia and dilutional hyponatremia. Attending physicians may ask the consultation/liaison psychiatrist to see schizophrenics with hyponatremically-induced delirium or other psychiatric syndromes. The referring physician may or may not have identified polydipsia and dilutional hyponatremia and their complications. This article will help the consultation/liaison psychiatrist recognize early evidence of water imbalance, describe evaluation, and provide somatic and behavioral treatment approaches to this life-threatening syndrome.
Over the past ten years, the authors have treated more than 100 patients with the polydipsia-hyponatremia syndrome. The authors discuss their and others' experience with drugs that help and hinder patients suffering from dilutional hyponatremia. They review current key articles from the polydipsia-hyponatremia syndrome literature including articles identified via Medline search 1985-94.
Schizophrenics with the polydipsia-hyponatremia syndrome most commonly present with polydipsia, polyuria, urinary incontinence, cognitive, affective, and behavioral changes, seizures, or coma. Quantitating polydipsia, hyponatremia, and diurnal changes in body weight facilitate therapeutic interventions. Treatment include patient and caregiver education, drug therapies to better treat psychosis and better treat osmotic dysregulation, behavioral interventions to interdict polydipsia, and diurnal weight monitoring.
Once recognized, acute, subacute, and chronic complications of the polydipsia-hyponatremia syndrome are readily treatable. Besides treating the patient, consultation/liaison psychiatrists can teach their medical colleagues about this syndrome. In so doing, they will enhance the quality of their patients' lives and help the internist and surgeon feel more comfortable when working with schizophrenics.
作者旨在加深对伴有烦渴和稀释性低钠血症并发症的住院精神分裂症患者的理解并改善其治疗。主治医生可能会要求会诊/联络精神科医生诊治患有低钠血症所致谵妄或其他精神综合征的精神分裂症患者。转诊医生可能已经或尚未识别出烦渴和稀释性低钠血症及其并发症。本文将帮助会诊/联络精神科医生识别早期水代谢失衡迹象,描述评估方法,并提供针对这种危及生命综合征的躯体和行为治疗方法。
在过去十年中,作者治疗了100多名患有烦渴-低钠血症综合征的患者。作者讨论了他们自己以及其他人使用有助于和阻碍稀释性低钠血症患者的药物的经验。他们回顾了烦渴-低钠血症综合征文献中的当前关键文章,包括通过1985 - 1994年医学文献数据库检索识别出的文章。
患有烦渴-低钠血症综合征的精神分裂症患者最常见的表现为烦渴、多尿、尿失禁、认知、情感和行为改变、癫痫发作或昏迷。对烦渴、低钠血症和体重的日间变化进行量化有助于进行治疗干预。治疗包括对患者及其护理人员的教育、更好地治疗精神病和渗透压调节异常的药物治疗、阻止烦渴的行为干预以及日间体重监测。
一旦被识别,烦渴-低钠血症综合征的急性、亚急性和慢性并发症很容易治疗。除了治疗患者外,会诊/联络精神科医生还可以向他们的医学同事传授这种综合征的相关知识。这样做,他们将提高患者的生活质量,并帮助内科医生和外科医生在治疗精神分裂症患者时更加得心应手。